Mixed but Mostly Promising Results With IL-6 Inhibitor in Uveitic Macular Edema

(MedPage Today) — ORLANDO — The investigational interleukin (IL)-6 inhibitor vamikibart led to visual improvements in uveitic macular edema in two identical phase III trials, with one exception. In the MEERKAT trial, the adjusted proportion…